Literature DB >> 3881760

Macrophage activation by monosaccharide precursors of Escherichia coli lipid A.

M Nishijima, F Amano, Y Akamatsu, K Akagawa, T Tokunaga, C R Raetz.   

Abstract

Certain Escherichia coli mutants defective in phosphatidylglycerol biosynthesis accumulate two novel glycolipids, designated X and Y. Lipid X is a diacylglucosamine 1-phosphate bearing beta-hydroxymyristoyl groups at positions 2 and 3, and lipid Y has the same structure as X, except for the additional presence of a palmitoyl moiety on the N-linked beta-hydroxymyristate. We have examined the activities of X, Y, and several related compounds as activators of macrophages. Both X and Y induce morphological changes (spreading), prostaglandin E2 synthesis, and killing of tumor cells by mouse peritoneal macrophages in vitro, properties with which lipopolysaccharide and lipid A are also endowed. Both glycolipids have similar effects on the macrophage-like mouse cell line J774.1. Selective removal from lipid X of either the ester-linked beta-hydroxymyristate at position 3 or the phosphate at position 1 abolishes activity. Our results show that the monosaccharides X and Y retain some of the properties of intact lipopolysaccharide and lipid A with respect to macrophage activation. Because the structures of X and Y are defined, our findings should facilitate the elucidation of the molecular mechanism of macrophage activation by lipid A.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3881760      PMCID: PMC397021          DOI: 10.1073/pnas.82.2.282

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

1.  Direct augmentation of cytolytic activity of tumor-derived macrophages and macrophage cell lines by muramyl dipeptide.

Authors:  T Taniyama; H T Holden
Journal:  Cell Immunol       Date:  1979-12       Impact factor: 4.868

2.  Membrane lipid biogenesis in Escherichia coli: identification of genetic loci for phosphatidylglycerophosphate synthetase and construction of mutants lacking phosphatidylglycerol.

Authors:  M Nishijima; C R Raetz
Journal:  J Biol Chem       Date:  1979-08-25       Impact factor: 5.157

Review 3.  Biochemical criteria for activated macrophages.

Authors:  M L Karnovsky; J K Lazdins
Journal:  J Immunol       Date:  1978-09       Impact factor: 5.422

Review 4.  Activation of mononuclear phagocytes: fact, fancy, and future.

Authors:  Z A Cohn
Journal:  J Immunol       Date:  1978-09       Impact factor: 5.422

Review 5.  The outer membrane of Gram-negative bacteria.

Authors:  H Nikaido; T Nakae
Journal:  Adv Microb Physiol       Date:  1979       Impact factor: 3.517

Review 6.  Bacterial endotoxins and host immune responses.

Authors:  D C Morrison; J L Ryan
Journal:  Adv Immunol       Date:  1979       Impact factor: 3.543

7.  Characterization of two membrane-associated glycolipids from an Escherichia coli mutant deficient in phosphatidylglycerol.

Authors:  M Nishijima; C R Raetz
Journal:  J Biol Chem       Date:  1981-10-25       Impact factor: 5.157

8.  Chemical, physicochemical and biological properties of bacterial lipopolysaccharides.

Authors:  C Galanos; M A Freudenberg; O Lüderitz; E T Rietschel; O Westphal
Journal:  Prog Clin Biol Res       Date:  1979

9.  The chemical structure of lipid A. Demonstration of amide-linked 3-acyloxyacyl residues in Salmonella minnesota Re lipopolysaccharide.

Authors:  H W Wollenweber; K W Broady; O Lüderitz; E T Rietschel
Journal:  Eur J Biochem       Date:  1982-05

10.  Two interacting mutations causing temperature-sensitive phosphatidylglycerol synthesis in Escherichia coli membranes.

Authors:  M Nishijima; C E Bulawa; C R Raetz
Journal:  J Bacteriol       Date:  1981-01       Impact factor: 3.490

View more
  21 in total

1.  A lipopolysaccharide (LPS)-resistant mutant isolated from a macrophagelike cell line, J774.1, exhibits an altered activated-macrophage phenotype in response to LPS.

Authors:  F Amano; Y Akamatsu
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

2.  Immunostimulatory, but not antiendotoxin, activity of lipid X is due to small amounts of contaminating N,O-acylated disaccharide-1-phosphate: in vitro and in vivo reevaluation of the biological activity of synthetic lipid X.

Authors:  C Lam; J Hildebrandt; E Schütze; B Rosenwirth; R A Proctor; E Liehl; P Stütz
Journal:  Infect Immun       Date:  1991-07       Impact factor: 3.441

3.  Effect of protein kinase C inhibitor (H-7) and calmodulin antagonist (W-7) on pertussis toxin-induced IL-1 production by human adherent monocytes. Comparison with lipopolysaccharide as a stimulator of IL-1 production.

Authors:  H Taniguchi; T Sakano; T Hamasaki; H Kashiwa; K Ueda
Journal:  Immunology       Date:  1989-06       Impact factor: 7.397

4.  Elimination and tissue distribution of the monosaccharide lipid A precursor, lipid X, in mice and sheep.

Authors:  D T Golenbock; S Ebert; J A Will; R A Proctor
Journal:  Antimicrob Agents Chemother       Date:  1988-01       Impact factor: 5.191

5.  Induction of early gene expression in murine macrophages by synthetic lipid A analogs with differing endotoxic potentials.

Authors:  P Y Perera; C L Manthey; P L Stütz; J Hildebrandt; S N Vogel
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

6.  Inhibition of endotoxin-induced priming of human neutrophils by lipid X and 3-Aza-lipid X.

Authors:  R L Danner; K A Joiner; J E Parrillo
Journal:  J Clin Invest       Date:  1987-09       Impact factor: 14.808

7.  Biological activities of chemically synthesized 2-keto-3-deoxyoctonic acid-(alpha 2----6)-D-glucosamine analogs of lipid A.

Authors:  T Shimizu; S Akiyama; T Masuzawa; Y Yanagihara; S Nakamoto; K Achiwa
Journal:  Infect Immun       Date:  1987-09       Impact factor: 3.441

8.  Requirement of a properly acylated beta(1-6)-D-glucosamine disaccharide bisphosphate structure for efficient manifestation of full endotoxic and associated bioactivities of lipid A.

Authors:  I Takahashi; S Kotani; H Takada; M Tsujimoto; T Ogawa; T Shiba; S Kusumoto; M Yamamoto; A Hasegawa; M Kiso
Journal:  Infect Immun       Date:  1987-01       Impact factor: 3.441

9.  Lipid X ameliorates pulmonary hypertension and protects sheep from death due to endotoxin.

Authors:  D T Golenbock; J A Will; C R Raetz; R A Proctor
Journal:  Infect Immun       Date:  1987-10       Impact factor: 3.441

10.  Pretranslational regulation of the synthesis of the third component of complement in human mononuclear phagocytes by the lipid A portion of lipopolysaccharide.

Authors:  R C Strunk; A S Whitehead; F S Cole
Journal:  J Clin Invest       Date:  1985-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.